STLN
The Oncology Institute, Inc.
6.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -24.5% | -11.2% | -6.7% | -4.9% | |
| 1.7% | 1.8% | 1.6% | 1.4% | |
| 11.0% | 5.5% | 2.8% | 0.9% | |
| -8.1% | 0.7% | 4.6% | 0.3% | |
| 2.2% | 1.4% | 1.0% | 0.6% | |
| – | – | – | -0.6% | |
| -3.6% | -0.3% | 0.0% | – | |
| 43.5% | 0.0% | 0.0% | -4.0% | |
| 36.5% | -2.1% | -0.9% | 2.3% | |
| -40.1% | 6.0% | 4.1% | -3.2% | |
| -26.6% | -12.6% | -7.7% | -5.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.